Conference Coverage

Safety of sentinel node dissection alone holds up a decade out


 

AT THE 2016 ASCO ANNUAL MEETING

References

In a related analysis of radiation protocol deviations in a subset of women from the trial, 11% did not receive any radiation therapy, while 18.9% received third-field radiation, with equal distribution of the latter between study groups (J Clin Oncol. 2014;32:3600-6). Omission of radiation was associated with an increased risk of local recurrence and death, but it did not affect nodal recurrences. Receipt of third-field radiation did not influence survival.

tor@frontlinemedcom.com

Pages

Recommended Reading

Adjuvant AI therapy for breast cancer: 10 years is superior to 5 years
MDedge Hematology and Oncology
Immune agonist, checkpoint inhibitor combo shows good tolerability
MDedge Hematology and Oncology
In-person, telephone genetic counseling yield similar outcomes
MDedge Hematology and Oncology
FDA reports shortage of doxorubicin for injection, initiates importation
MDedge Hematology and Oncology
Point/Counterpoint: Should breast MRI be used routinely in the preoperative evaluation of breast cancer?
MDedge Hematology and Oncology
Long-term community-based results of breast-conserving therapy in early-stage breast cancer
MDedge Hematology and Oncology
Hereditary breast and ovarian cancer: risk assessment in minority women and provider knowledge gaps
MDedge Hematology and Oncology
Group-based psychosocial services: assessing outpatient oncology needs
MDedge Hematology and Oncology
I-SPY 2 graduates two neoadjuvant treatments to phase III trials
MDedge Hematology and Oncology
Ipsilateral arm BP measurements after breast cancer?
MDedge Hematology and Oncology